Clinical Trial Update: Therapeutic Dose Monitoring (TDM) of Tamoxifen [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on therapeutic dose monitoring of tamoxifen for breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: Karolinska University Hospital | Conditions: Breast Cancer, Breast Carcinoma | Phase 2 | Status: UNKNOWN